GENPF (Genix Pharmaceuticals) Net Margin %: 0.00% (As of Jan. 2026)


What is Genix Pharmaceuticals Net Margin %?

Genix Pharmaceuticals GENPF Net Margin % is 0.00% as of Jan. 2026. The stock has 3 warning signs investors should review. Among 953 Drug Manufacturers companies, Genix Pharmaceuticals ranks worse than 104931.69% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Genix Pharmaceuticals's Net Income for the three months ended in Jan. 2026 was $-0.04 Mil. Genix Pharmaceuticals's Revenue for the three months ended in Jan. 2026 was $0.00 Mil. Therefore, Genix Pharmaceuticals's net margin for the quarter that ended in Jan. 2026 was 0.00%.

The historical rank and industry rank for Genix Pharmaceuticals's Net Margin % or its related term are showing as below:


GENPF's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.69
* Ranked among companies with meaningful Net Margin % only.

Genix Pharmaceuticals  (OTCPK:GENPF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Genix Pharmaceuticals Net Margin % Related Terms

Genix Pharmaceuticals Net Margin % Historical Data

* Premium members only.

The historical data trend for Genix Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals Net Margin % Chart

Genix Pharmaceuticals Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -35,622.22 -1,766.67 0.00

Genix Pharmaceuticals Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GENPF vs ZTS, UTHR: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genix Pharmaceuticals Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's Net Margin % falls into.


Genix Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Genix Pharmaceuticals's Net Margin for the fiscal year that ended in Oct. 2025 is calculated as

Net Margin=Net Income (A: Oct. 2025 )/Revenue (A: Oct. 2025 )
=-0.239/0
= %

Genix Pharmaceuticals's Net Margin for the quarter that ended in Jan. 2026 is calculated as

Net Margin=Net Income (Q: Jan. 2026 )/Revenue (Q: Jan. 2026 )
=-0.038/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Genix Pharmaceuticals (GENPF) has a Net Margin % of 0.00% as of Jan. 2026. Net margin is the ratio of total net income to net sales. View historical data on Genix Pharmaceuticals and its competitors. According to the industry distribution chart, Genix Pharmaceuticals ranks #999999 out of 953 companies in the Drug Manufacturers industry.
Is Genix Pharmaceuticals' Net Margin % too high?
Genix Pharmaceuticals' current Net Margin % is 0.00%. Based on the distribution chart, Genix Pharmaceuticals ranks #999999 out of 953 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Genix Pharmaceuticals' Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Genix Pharmaceuticals ranks #999999 out of 953 companies for Net Margin %. This places Genix Pharmaceuticals in the lower half of its industry. The industry median Net Margin % is 5.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.69, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Genix Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genix Pharmaceuticals's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genix Pharmaceuticals stock overvalued right now?
Genix Pharmaceuticals (GENPF) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Genix Pharmaceuticals (GENPF), the current Net Margin % is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genix Pharmaceuticals Business Description

Other Exchanges GENX:Canada
Address 1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically the company operates only in Canada.